New Rochelle, NY, United States of America

Vincent K Tsiagbe

USPTO Granted Patents = 4 

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2006-2019

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Vincent K Tsiagbe: Innovator in Cancer Diagnosis and Treatment

Introduction

Vincent K Tsiagbe is a notable inventor based in New Rochelle, NY (US). He has made significant contributions to the field of cancer diagnosis and treatment, holding a total of 4 patents. His work focuses on innovative methods that enhance the understanding and management of cancer.

Latest Patents

Tsiagbe's latest patents include groundbreaking methods for the diagnosis of cancer through the detection of human endogenous retrovirus WL (HERV-WL) envelope expression. This invention relates to methods and kits designed for the diagnosis of cancer in subjects by detecting HERV-WL polypeptides. Additionally, he has developed therapeutic uses of inhibitors of the lymphotoxin pathway to treat tumors, specifically targeting follicular lymphomas.

Career Highlights

Throughout his career, Tsiagbe has worked with prominent organizations such as Biogen Idec and New York University. His experience in these institutions has allowed him to collaborate with leading experts in the field, further enhancing his contributions to cancer research.

Collaborations

Some of Tsiagbe's notable coworkers include Jeffrey L Browning and Jeanette Thorbecke. Their collaborative efforts have played a crucial role in advancing research and innovation in cancer treatment.

Conclusion

Vincent K Tsiagbe's work exemplifies the impact of innovation in the medical field, particularly in cancer diagnosis and treatment. His patents and collaborations reflect a commitment to improving patient outcomes through scientific advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…